[go: up one dir, main page]

FI953934L - Farnesyyli:proteiinitransferaasin inhibiittoreja, jotka toimivat syöpää vastaan vaikuttavina aineina - Google Patents

Farnesyyli:proteiinitransferaasin inhibiittoreja, jotka toimivat syöpää vastaan vaikuttavina aineina Download PDF

Info

Publication number
FI953934L
FI953934L FI953934A FI953934A FI953934L FI 953934 L FI953934 L FI 953934L FI 953934 A FI953934 A FI 953934A FI 953934 A FI953934 A FI 953934A FI 953934 L FI953934 L FI 953934L
Authority
FI
Finland
Prior art keywords
farnesyl
act
anticancer agents
protein transferase
transferase inhibitors
Prior art date
Application number
FI953934A
Other languages
English (en)
Swedish (sv)
Other versions
FI953934A0 (fi
FI111369B (fi
Inventor
David Martin Stemerick
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1994/000929 external-priority patent/WO1994019357A1/en
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI953934A0 publication Critical patent/FI953934A0/fi
Publication of FI953934L publication Critical patent/FI953934L/fi
Application granted granted Critical
Publication of FI111369B publication Critical patent/FI111369B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015Esters of acyclic unsaturated acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3821Acyclic saturated acids which can have further substituents on alkyl substituted by B, Si, P or a metal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • C07F9/4012Esters of acyclic acids which can have further substituents on alkyl substituted by B, Si, P or a metal

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI953934A 1993-02-23 1995-08-22 Menetelmä yhdisteiden valmistamiseksi, jotka ovat syöpää vastaan vaikuttavia farnesyyli:proteiinitransferaasin inhibiittoreita FI111369B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2141193A 1993-02-23 1993-02-23
US2141193 1993-02-23
PCT/US1994/000929 WO1994019357A1 (en) 1993-02-23 1994-01-24 Farnesyl:protein transferase inhibitors as anticancer agents
US9400929 1994-01-24

Publications (3)

Publication Number Publication Date
FI953934A0 FI953934A0 (fi) 1995-08-22
FI953934L true FI953934L (fi) 1995-08-22
FI111369B FI111369B (fi) 2003-07-15

Family

ID=21804071

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953934A FI111369B (fi) 1993-02-23 1995-08-22 Menetelmä yhdisteiden valmistamiseksi, jotka ovat syöpää vastaan vaikuttavia farnesyyli:proteiinitransferaasin inhibiittoreita

Country Status (19)

Country Link
US (1) US5463181A (fi)
EP (1) EP0686159B1 (fi)
JP (1) JPH08509470A (fi)
KR (1) KR100305128B1 (fi)
CN (1) CN1045207C (fi)
AT (1) ATE159023T1 (fi)
AU (1) AU684071B2 (fi)
CA (1) CA2154871C (fi)
DE (1) DE69406110T2 (fi)
DK (1) DK0686159T3 (fi)
ES (1) ES2110738T3 (fi)
FI (1) FI111369B (fi)
GR (1) GR3025499T3 (fi)
HU (1) HUT72647A (fi)
IL (1) IL108694A0 (fi)
NO (1) NO306618B1 (fi)
NZ (1) NZ262585A (fi)
TW (1) TW265345B (fi)
ZA (1) ZA941099B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
FR2833266B1 (fr) * 2001-12-11 2004-10-22 Mayoly Spindler Lab Nouveaux derives phosphonates, leur procede de preparation, leur utilisation comme modulateurs de l'activite des lymphocytes tgamma9 delta2
CA2789097C (en) 2005-04-28 2017-02-21 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57142993A (en) * 1981-02-28 1982-09-03 Sagami Chem Res Center 2-hydroxyphosphonic diester
DE3313070A1 (de) * 1983-04-12 1984-10-18 Bayer Ag, 5090 Leverkusen Chlorierte phosphorylmethylcarbonyl-derivate, verfahren zu ihrer herstellung und ihre verwendung in pflanzenschutmitteln
DE3425701A1 (de) * 1984-07-12 1986-01-16 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von chlorierten phosphorylmethylcarbonyl-derivaten und neue zwischenprodukte zu ihrer herstellung
US4924024A (en) * 1988-01-11 1990-05-08 E. R. Squibb & Sons, Inc. Phosphorus-containing squalene synthetase inhibitors, new intermediates and method
US5177239A (en) * 1989-07-18 1993-01-05 E. R. Squibb & Sons, Inc. Method for preparing a phosphonic acid ester
US5298655A (en) * 1991-09-27 1994-03-29 Merck & Co., Inc. Farnesyl pyrophosphate analogs

Also Published As

Publication number Publication date
CN1045207C (zh) 1999-09-22
HUT72647A (en) 1996-05-28
EP0686159B1 (en) 1997-10-08
FI953934A0 (fi) 1995-08-22
FI111369B (fi) 2003-07-15
US5463181A (en) 1995-10-31
GR3025499T3 (en) 1998-02-27
CN1118166A (zh) 1996-03-06
CA2154871C (en) 1998-04-07
NZ262585A (en) 1997-12-19
ZA941099B (en) 1994-08-30
ES2110738T3 (es) 1998-02-16
TW265345B (fi) 1995-12-11
CA2154871A1 (en) 1994-09-01
ATE159023T1 (de) 1997-10-15
DE69406110D1 (de) 1997-11-13
DK0686159T3 (da) 1998-01-26
AU684071B2 (en) 1997-12-04
DE69406110T2 (de) 1998-05-14
EP0686159A1 (en) 1995-12-13
AU6232494A (en) 1994-09-14
NO953292D0 (no) 1995-08-22
HU9502455D0 (en) 1995-10-30
JPH08509470A (ja) 1996-10-08
NO306618B1 (no) 1999-11-29
KR100305128B1 (ko) 2001-11-22
NO953292L (no) 1995-08-22
IL108694A0 (en) 1994-05-30

Similar Documents

Publication Publication Date Title
EP0668856A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE.
FI952011A7 (fi) Farnesyyliproteiinitransferaasin estäjät
ATE185341T1 (de) 4,9-ethano-benzo(f)isoindolderivate als farnesyl transferase inhibitoren
EE9700314A (et) Farnesüül-proteiini transferaasi inhibiitorid
NO20024950D0 (no) 4-Merkaptopyrrolidinderivater som farnesyltransferaseinhibitorer
EE04309B1 (et) Farnesüül-proteiini transferaasi inhibiitorid
EE9800408A (et) Proteiinfarnesüültransferaasi inhibiitorid
EP0664789A4 (en) Inhibitors of farnesyl protein transferase.
NO961814D0 (no) Substituerte di- og tripetidinhibitorer for protein:farnesyl-transferase
ZA985778B (en) Inhibitors of farnesyl protein transferase.
NO973607D0 (no) Nye farnesyltransferaseinhibitorer, deres fremstilling og preparater inneholdende inhibitorene
FI945706A7 (fi) Proteiinikinaasi C-inhibiittoreita
EP0794789A4 (en) Inhibitors of prenyl transferases
FI951554A7 (fi) Imidatsolipitoisia farnesyyliproteiinitransferaasi-inhibiittoreita
DK1162201T3 (da) Farnesylproteintransferaseinhiberende (imidazol-5-yl)methyl-2-quinolinonderivater
EP1011669A4 (en) FARNESYL PROTEIN TRANSFERASE INHIBITORS
EP0784473A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
ATE293622T1 (de) Farnesyl protein transferase inhibitoren
EP0783305A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0812203A4 (en) INHIBITORS OF GERANYLGERANYL PROTEIN TRANSFERASE
DE69711081D1 (de) Farnesyl transferase inhibitoren
EP1035850A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP1035852A4 (en) FARNESYL PROTEIN TRANSFERASE INHIBITORS
FI953934L (fi) Farnesyyli:proteiinitransferaasin inhibiittoreja, jotka toimivat syöpää vastaan vaikuttavina aineina
NO20012961D0 (no) Trisykliske farnesylproteintransferase-inhibitorer